Clinical Trial Update: Enzalutamide Implants (Enolen) in Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Enolen (enzalutamide implants) for prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enolen (enzalutamide)

Snippet

Sponsor: Alessa Therapeutics Inc. | Conditions: Prostate Adenocarcinoma | Phase 1 | Status: RECRUITING